Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT03849963
- Status
- Recruiting
Conditions
- Brain Metabolism
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Study Details
Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.
Key Dates
- Start date
- Jul 30, 2030
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 28 participants (estimated)
Arms
- Arm: Hyperpolarized [13C]pyruvateHyperpolarized stable isotope injection (\[13C\]pyruvate) during magnetic resonance spectroscopic imaging
Primary Outcome Measure
Development of 13C ratio maps in the brain of healthy participants [ Time Frame: Measurements made during study scan ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT Southwestern - Advanced Imaging Research Center | Dallas | Texas | 75390 |
Find similar trials in Dallas, TX
By research site